AmbrosioniE, SafarM, DegauteJP, MalinPL, MacMahonM, PujolDR, et al. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: Results of randomized double-blind controlled studies. European study group. J Hypertens1998; 16: 1677–84. DOI 10.1097/00004872-199816110-00015
2.
NaranjoCA, BustoU, SellersEM, SandorP, RuizI, RobertsEA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.
3.
RenduF, BachelotC, MolleD, CaenJ, GuezD. Indapamide inhibits human platelet aggregation in vitro: Comparison with hydrochlorothiazide. Cardiovasc Pharmacol1993; 22 (suppl 6): S57–63.
4.
GroseJH, GbeassorFM, LebelM. Differential effects of diuretics on eicosanoid biosynthesis. Prostaglandin Leukot Med1986; 24: 103–9. DOI 10.1016/0262-1746(86)90118-6
5.
IakovlevVM, SokolovGS. [The possibilities of arifon in the combined therapy of unstable stenocardia in persons with arterial hypertension] Russian. Ter Arkh1997; 69 (6): 53–5.